Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082784
Status:
COMPLETED
Last Update Posted:
2014-12-23
First Post:
2004-05-14
Brief Title:
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Sponsor:
Organization:
National Cancer Institute NCI